NFDI4DS | UHH-SEMS - Publication Details

Eduard Callebout

ORCID: 0000-0003-1899-3410

Publications

Citations

Views

---

Saved

---

About

Contact & Profiles

A5080016283

Research Areas

Hepatocellular Carcinoma Treatment and Prognosis
Gastric Cancer Management and Outcomes
Neuroendocrine Tumor Research Advances
Intraperitoneal and Appendiceal Malignancies
Organ Transplantation Techniques and Outcomes
Lung Cancer Research Studies
Gastrointestinal Tumor Research and Treatment
Liver Disease Diagnosis and Treatment
Pancreatic and Hepatic Oncology Research
Esophageal Cancer Research and Treatment
Genetic factors in colorectal cancer
Ethics in medical practice
Cholangiocarcinoma and Gallbladder Cancer Studies
Liver Disease and Transplantation
Lung Cancer Diagnosis and Treatment
Neuroblastoma Research and Treatments
Drug-Induced Hepatotoxicity and Protection
Ethics and Legal Issues in Pediatric Healthcare
Palliative Care and End-of-Life Issues
Renal Transplantation Outcomes and Treatments
Transplantation: Methods and Outcomes
Health Systems, Economic Evaluations, Quality of Life
Pancreatitis Pathology and Treatment
Colorectal Cancer Treatments and Studies
Inflammatory Biomarkers in Disease Prognosis

Ghent University Hospital
2019-2024

Universitair Ziekenhuis Brussel
2023

Amsterdam University Medical Centers
2022

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

OPENALEX - Publications

Tiuri E. Kroese Richard van Hillegersberg Sebastian F. Schoppmann Pieter Deseyne Philippe Nafteux and 95 more

10.1016/j.ejca.2021.11.032 article EN European Journal of Cancer 2022-02-05

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

OPENALEX - Publications

Helena Degroote Eduard Callebout Samuele Iesari Jeroen Dekervel Jonas Schreiber and 11 more

10.1016/j.suronc.2019.10.006 article EN Surgical Oncology 2019-10-07

AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

OPENALEX - Publications

Federico Piñero Charlotte Costentin Helena Degroote Andrea Notarpaolo I.F.S.F. Boin and 89 more

10.1016/j.jhepr.2022.100644 article EN cc-by-nc-nd JHEP Reports 2022-12-05

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

OPENALEX - Publications

Eduard Callebout Suzane Ribeiro Stéphanie Laurent Marc De Man Liesbeth Ferdinande and 3 more

Non-V600E BRAF mutated colorectal cancer (CRC) is a rare disease entity with specific clinical features. These tumors are less likely to have microsatellite instability than CRC V600E mutation and often harbor KRAS or NRAS mutation. Notably, median overall survival longer in wild-type CRC. Little known about treatment possibilities these patients. We present the case of 59 year old patient codon 594, who progressed rapidly on all classical therapies but experienced clear long lasting...

10.1186/s12885-019-5763-5 article EN cc-by BMC Cancer 2019-06-11

Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: A Delphi consensus statement

OPENALEX - Publications

F. Tozzi Nikdokht Rashidian Wim Ceelen Eduard Callebout Martin Hübner and 47 more

10.1016/j.ejso.2024.108346 article EN European Journal of Surgical Oncology 2024-04-18

Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trial

OPENALEX - Publications

Dominique Benoît Aglaja De Pauw Celine Jacobs Ine Moors Fritz Offner and 21 more

10.1007/s00134-024-07588-0 article EN cc-by-nc Intensive Care Medicine 2024-09-04

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes

OPENALEX - Publications

Raghav Sundar Daryl Kai Ann Chia Jing Zhao Ainsley Ryan Yan Bin Lee Gyuri Kim and 29 more

10.1016/j.esmoop.2024.103681 article EN cc-by-nc-nd ESMO Open 2024-09-01

Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010–2019

OPENALEX - Publications

Marlies Maly Eduard Callebout Suzane Ribeiro Anne Hoorens Saskia Carton and 8 more

Abstract The prevalence of gastric NEN is estimated worldwide at 8.9% all gastroenteropancreatic neuroendocrine neoplasm (GEP‐NEN) and only 0.3%–1% neoplasms, but rising in the last decades. aim this project was to map epidemiology (gNEN) Belgium. This a population‐wide retrospective cohort study over 10 years (2010–2019), based on data from Belgian Cancer Registry. A total 641 patients were included; 605 with gNEN 36 MiNEN. AAIR 0.67 per 100,000 person‐years, increasing slight female...

10.1111/jne.13473 article EN Journal of Neuroendocrinology 2024-11-27

Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: a Delphi consensus statement

OPENALEX - Publications

F. Tozzi Nikdokht Rashidian Wim Ceelen Eduard Callebout Martin Hübner and 2 more

10.1016/j.ejso.2024.109185 article EN European Journal of Surgical Oncology 2024-12-01

1550P Evaluating the novel combination of pressurized intraperitoneal aerosol chemotherapy-oxaliplatin (PIPAC-OX) as an immunomodulator in combination with systemic nivolumab for gastric cancer peritoneal metastases

OPENALEX - Publications

Raghav Sundar Daryl Kai Ann Chia Wim Ceelen C. Chia G. Kim and 15 more

10.1016/j.annonc.2023.09.1462 article EN publisher-specific-oa Annals of Oncology 2023-10-01

Familiale adenomateuze polypose: huidige stand van zaken en nut van surveillance en chemopreventie

OPENALEX - Publications

Eduard Callebout DE MAN M Karen Geboes

10.47671/tvg.74.03.2002518 article NL Tijdschrift voor Geneeskunde 2018-01-01

Coming Soon ...